Farmacia Hospitalaria y Farmacogenómica

Ramirez-Herraiz, E; Escudero-Vilaplana, V; Alanon-Plaza, E; Trovato-Lopez, N; Herranz-Alonso, A; Morell-Baladron, A; Sanjurjo-Saez, M.

Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013; 31(4): 559-565 Nº de citas: 29

Cortejoso, L; Garcia, MI; Garcia-Alfonso, P; Gonzalez-Haba, E; Escolar, F; Sanjurjo, M; Lopez-Fernandez, LA.

Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer

CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2013; 71(6): 1463-1472 Nº de citas: 45 [doi:10.1007/s00280-013-2145-6]

Fernandez-Rozadilla, C; Cazier, JB; Moreno, V; Crous-Bou, M; Guino, E; Duran, G; Lamas, MJ; Lopez, R; Candamio, S; Gallardo, E; Pare, L; Baiget, M; Paez, D; Lopez-Fernandez, LA; Cortejoso, L; Garcia, MI; Bujanda, L; Gonzalez, D; Gonzalo, V; Rodrigo, L; Rene, JM; Jover, R; Brea-Fernandez, A; Andreu, M; Bessa, X; Llor, X; Xicola, R; Palles, C; Tomlinson, I; Castellvi-Bel, S; Castells, A; Ruiz-Ponte, C; Carracedo, A.

Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration

PHARMACOGENOMICS JOURNAL. 2013; 13(3): 209-217 Nº de citas: 46 [doi:10.1038/tpj.2012.2]

Escudero-Vilaplana, V; Martinez-Nieto, C; Lopez-Gomez, JM; Vega-Martinez, A; Bellon-Cano, JM; Sanjurjo-Saez, M.

Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis

International Journal of Clinical Pharmacy. 2013; 35(3): 463-468 Nº de citas: 6 [doi:10.1007/s11096-013-9774-z]

Romero Jimenez, RM; Calleja Hernandez, MA; Chaparro Recio, M; Martinez Martinez, F; Sanjurjo Saez, M.

Effect of Pharmacotherapy Follow-Up on Treatment Adherence and Virologic and Immune Response in Patients with Human Immunodeficiency Virus

Latin American Journal of Pharmacy. 2013; 32(3): 441-447 Nº de citas: 2

Escudero-Vilaplana, V; Martinez-Nieto, C; Lopez-Gomez, JM; Vega-Martinez, A; Sanjurjo-Saez, M.

Equipotent Doses of Erythropoiesis-Stimulating Agents in Outpatients with Anaemia Secondary to Chronic Kidney Disease

Latin American Journal of Pharmacy. 2013; 32(3): 454-458

Rallon, NI; Lopez-Fernandez, LA; Garcia, MI; Benguria, A; Fiorante, S; Soriano, V; Benito, JM.

Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients

AIDS. 2013; 27(5): 687-696 Nº de citas: 10 [doi:10.1097/QAD.0b013e32835ce2c1]

Fernandez-Rozadilla, C; Palles, C; Carvajal-Carmona, L; Peterlongo, P; Nici, C; Veneroni, S; Pinheiro, M; Teixeira, MR; Moreno, V; Lamas, MJ; Baiget, M; Lopez-Fernandez, LA; Gonzalez, D; Brea-Fernandez, A; Clofent, J; Bujanda, L; Bessa, X; Andreu, M; Xicola, R; Llor, X; Jover, R; Castells, A; Castellvi-Bel, S; Carracedo, A; Tomlinson, I; Ruiz-Ponte, C.

BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populations

CARCINOGENESIS. 2013; 34(2): 314-318 Nº de citas: 16 [doi:10.1093/carcin/bgs357]

Fernandez-Llamazares, CM; Hernandez-Gago, Y; Pozas, M; Cabanas, MJ; Feal, B; Villaronga, M; Alvarez-del-Vayo, C; Valverde, E.

Two-round Delphi technique for the consensual design of a paediatric pharmaceutical care model

PHARMACOLOGICAL RESEARCH. 2013; 68(1): 31-37 Nº de citas: 23 [doi:10.1016/j.phrs.2012.11.001]

Yeste-Gomez, I; Rodriguez-Gonzalez, CG; Gimenez-Manzorro, A; Ais-Larisgoitia, A; Sanjurjo-Saez, M.

Information leaflets for patients with hepatitis C receiving treatment with triple therapy

European Journal of Hospital Pharmacy-Science and Practice. 2013; 20(1): 13-19 Nº de citas: 2 [doi:10.1136/ejhpharm-2012-000176]

Fernandez-Rozadilla, C; Cazier, JB; Tomlinson, IP; Carvajal-Carmona, LG; Palles, C; Lamas, MJ; Baiget, M; Lopez-Fernandez, LA; Brea-Fernandez, A; Abuli, A; Bujanda, L; Clofent, J; Gonzalez, D; Xicola, R; Andreu, M; Bessa, X; Jover, R; Llor, X; Moreno, V; Castells, A; Carracedo, A; Castellvi-Bel, S; Ruiz-Ponte, C.

A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12

BMC GENOMICS. 2013; 14: Nº de citas: 35 [doi:10.1186/1471-2164-14-55]

de Lorenzo-Pinto, A; Rodriguez-Gonzalez, CG; Ais-Larisgoitia, A.

Emerging therapies for multiple sclerosis

MEDICINA CLINICA. 2013; 140(2): 76-82 Nº de citas: 2 [doi:10.1016/j.medcli.2012.05.008]

Escudero Vilaplana, V.; Plata Paniagua, S.; Rodríguez González, C.; Castillo Romera, I.; Ais Larisgoitia, A.; SANJURJO SAEZ, MARÍA.

[Permanence of last generation antiretroviral in daily clinical practice].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2013; 37(2): 151-156

Escudero-Vilaplana V; Plata-Paniagua; Ais A; Rodríguez-González C; Bellón Cano JM; SANJURJO SAEZ, MARÍA.

Equipotent doses of pegylated epoetin ß (CERA) for the treatment of outcome patients with anemia secondary to chronic kidney disease in clinical practice

European Journal of Clinical Pharmacy. 2013; 15(1): 55-58

Ribed, A; Quiroga, B; Romero-Jimenez, RM; Pernia, S; Escudero-Vilaplana, V; Sanjurjo-Saez, M.

Oral Ammonium Chloride, Treatment in Severe Metabolic Alkalosis

Latin American Journal of Pharmacy. 2013; 32(10): 1578-1580 Nº de citas: 1

de Lorenzo-Pinto, A; Cortejoso, L; Muino-Miguez, A; Gomez-Antunez, M; Duran-Garcia, E; Herranz-Alonso, A; Garcia-Sanchez, R; Sanjurjo-Saez, M.

Adequacy of Thromboembolic Prophylaxis Prescribed in an Emergency Department

Latin American Journal of Pharmacy. 2013; 32(8): 1205-1211 Nº de citas: 1

Fernandez-Llamazares, CM; Pozas, M; Juarez-Gimenez, JC; Hernandez-Gago, Y; Feal, B; Cabanas, MJ; Villaronga, M; Valverde, E; Alvarez-del Vayo, C.

Development of a Paediatric Pharmaceutical Care Model for validating prescriptions orders in Spanish Hospitals

AN REAL ACAD NACL F. 2013; 79(3): 481-504

Del Mazo, J; Brieno-Enriquez, MA; Garcia-Lopez, J; Lopez-Fernandez, LA; De Felici, M.

Endocrine disruptors, gene deregulation and male germ cell tumors

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. 2013; 57(2-4): 225-239 Nº de citas: 35 [doi:10.1387/ijdb.130042jd]